2026. ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW. Proceedings of the Global Public Health Conference. 9, 01 (Jun. 2026), 14–30. DOI:https://doi.org/10.17501/26138417.2026.9102.